5-iodotubercidin has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, T; Mori, Y; Sugiyama, H; Takahashi, N; Tomonaga, A | 1 |
| Carneiro, FS; Carneiro, ZN; Giachini, FRC; Inscho, EW; Leite, R; Lima, VV; Tostes, RC; Webb, RC | 1 |
| Gäbel, J; Lebrun, P; Malaisse, WJ; Pirotte, B; Rorsman, P; Valverde, I; Van Poelje, PD; Villanueva-Peñacarrillo, ML; Viñambres, C | 1 |
3 other study(ies) available for 5-iodotubercidin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Identification of allosteric ERK2 inhibitors through in silico biased screening and competitive binding assay.
Topics: Allosteric Site; Animals; Binding Sites; Binding, Competitive; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Design; Inhibitory Concentration 50; Mice; Mitogen-Activated Protein Kinase 1; Molecular Dynamics Simulation; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary | 2016 |
Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.
Topics: Acetylcholine; Adenosine; Adenosine Kinase; Animals; Diabetes Mellitus, Type 2; Dipyridamole; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Male; Mice; Mice, Mutant Strains; Mice, Obese; Muscle Contraction; Muscle, Smooth; Nitroprusside; Penis; Phenylephrine; Phosphodiesterase Inhibitors; Tubercidin; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
The riddle of formycin A insulinotropic action.
Topics: Adenosine; Animals; Calcium; Diabetes Mellitus, Type 2; Diazoxide; Female; Formycins; Glucose; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Rats; Ribonucleotides; Tubercidin; Verapamil; Xanthines | 1996 |